Bilateral Cystoid Macular Edema with Zanubrutinib Therapy: A Case Report

Bilateral Cystoid Macular Edema with Zanubrutinib Therapy: A Case Report

Abstract We present a patient with recurrent mantle cell lymphoma (MCL) who was treated with zanubrutinib, a Bruton’s tyrosine kinase inhibitor. He subsequently developed bilateral cystoid macular edema (CME) in both eyes. This is the first report of CME in a patient with MCL who was treated with za...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Case Reports in Oncology 2023-01, Vol.16 (1), p.525-530
Hauptverfasser: Pennipede, Dante, Sciulli, Harrison, Ajlan, Radwan
Format: Artikel
Sprache:eng
Schlagworte:
Case Report
Case reports
Causes of
Collaboration
cystoid macular edema
Diagnosis
Drug therapy
Edema
Eye diseases
Glaucoma
Lymphoma
Mantle cell lymphoma
Nervous system
Oncology
Patients
Retina
Signal transduction
Steroids
Tomography
Transplants & implants
zanubrutinib
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract We present a patient with recurrent mantle cell lymphoma (MCL) who was treated with zanubrutinib, a Bruton’s tyrosine kinase inhibitor. He subsequently developed bilateral cystoid macular edema (CME) in both eyes. This is the first report of CME in a patient with MCL who was treated with zanubrutinib. CME was refractory to topical corticosteroid therapy, but sub-Tenon’s steroid injections and holding off zanubrutinib managed to decrease the CME. Treatment managed to prevent further vision loss but did not restore lost vision. The prompt ophthalmic exam is recommended for patients on zanubrutinib with decreased vision.
ISSN:1662-6575
1662-6575
DOI:10.1159/000529069